NCT02778919View on ClinicalTrials.gov

Late Phase II Clinical Study of KLH-2109 in Patients With Endometriosis

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

May 9, 2016

Primary Completion Date

March 23, 2018

Study Completion Date

March 23, 2018

Conditions
Endometriosis
Interventions
DRUG

KLH-2109

DRUG

Placebo

DRUG

Leuprorelin acetate

Trial Locations (1)

Unknown

Multiple Locations

Sponsors
All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY

NCT02778919 - Late Phase II Clinical Study of KLH-2109 in Patients With Endometriosis | Biotech Hunter | Biotech Hunter